A word from Marek Kiecana
Dear Sir or Madam!
KCR S.A. is a company conducting clinical research phases II-IV, starting from drafting all the research documents until the final report. Clinical research conducted in accordance with GCP (Good Clinical Practice) principles constitutes an integral element in providing safe and effective medicaments. Our company operates in Europe and ensures effectiveness of conducted projects.
We want our clients to be confident that our work is characterized by the utmost diligence. We understand the role of pharma and biotech companies striving to provide safe and effective medicaments on the market. We also understand the expectations of patients using the drug. We want them to be sure of the medicine’s effectiveness. We do not want their lives to be gloomed by the poor results of medication nor by any kind of dissatisfaction.
This assertion results from the fact that we try to understand our clients, our researchers, and our patients better. What leads to that is not only our organizational and scientific professionalism but also our desire to serve those who suffer. We practice this kind of service through clinical and scientific efforts. Believing that we grow in our humanity as much as we are able to give our love and understanding to others, to the sick and suffering, we remain open to the latest innovations.
In our conduct, we wish to remind and popularize the idea of man’s being a creature of utmost value, never a means or a tool. He is God’s creation and we want to show due respect for every human being as well as for their Maker through our commitment to the job. Carrying out our projects, it is our goal to restore the patients’ wellbeing and make it possible for them to enjoy the fullness of it.
We wish our research to instill hope for man’s better future. Contributing to the latest medical advancement, we want to play an active role in elimination of diseases and bringing relief to suffering. We thus build trust in the possibilities of science as well as in human solidarity.
It is our desire for the drugs tested in our projects to serve the sick and bring about the intended result: hope and wellbeing.
Marek Kiecana